VenoStent, Inc.

VenoStent, Inc. is a clinical-stage therapeutic medical device company dedicated to improving outcomes in vascular surgery, particularly for patients undergoing hemodialysis. They are developing a novel bioabsorbable perivascular wrap called SelfWrap, designed to address the high failure rate of arteriovenous (AV) access sites used for dialysis. SelfWrap aims to improve the maturation and durability of these sites by providing biomimetic mechanical support, improving hemodynamics, and promoting outward vein growth. This technology, if successful, has the potential to significantly improve the quality of life for patients with chronic kidney disease requiring hemodialysis.

VenoStent is a company driven by innovation and is actively involved in clinical trials and partnerships with leading research institutions. They have secured funding from both public and private sources, including the National Science Foundation, National Institutes of Health, and venture capital firms. The company is also actively involved in the development of its technology and building strategic partnerships with other companies in the healthcare space. VenoStent has a strong team of experts in biomedical engineering, materials engineering, and medical 3D printing, driving their commitment to improving the lives of vascular surgery patients.

VenoStent is a clinical-stage therapeutic medical device company focused on improving outcomes for vascular surgery patients. Their innovative, bioabsorbable wraps, like SelfWrap, are designed to improve the usability and durability of arteriovenous access sites, which are crucial for patients undergoing hemodialysis. By developing these innovative materials and technologies, VenoStent aims to transform vascular surgery and improve the quality of life for millions of patients around the world.

VenoStent's culture emphasizes innovation, collaboration, and a dedication to improving the lives of patients. The company brings together a diverse team of experts in fields such as biomedical engineering, materials engineering, and medical 3D printing. They foster a collaborative environment through their participation in accelerator programs and partnerships with institutions like the Texas Medical Center and Johnson & Johnson's JLabs, allowing for knowledge sharing and growth. Their dedication to patient care is evident in their focus on developing solutions to address critical challenges in vascular surgery, particularly for patients requiring hemodialysis.